Therapy Architects designs and develops novel targeted cancer therapies for both children and adults.
See More About UsCancer develops due to specific changes such as a mutation or phosphorylation of key molecules (target) in normal cells leading to its altered function. These changes are often patient specific.
Patients taking a particular drug for their cancer treatment often become resistant to that drug. This resistance is due to new mutations that occur in target molecules of the cancer cells.
The outer surface of cancer cells has molecules designated as cancer biomarkers, that are absent in normal cells. These biomarkers are useful for drug delivery.
Therapy Architects designs and develops novel targeted cancer therapies for both children and adults. Every patient is unique and not all respond to available products. Our team is focused on improving outcomes by optimizing efficacy and reducing toxic side effects of chemotherapeutic agents where, the cure can sometimes be worse than the disease itself.
© 2016 Therapy Architects. All rights reserved
